Abstract: Antibodies having dual specificity for two different but structurally related antigens are provided. The antibodies can be, for example, entirely human antibodies, recombinant antibodies, or monoclonal antibodies. Preferred antibodies have dual specificity for il-1 alpha and il-1 beta and neutralize il-1 alpha and il-1 beta activity in vitroand in vivo. An antibody of the invention can be full-length antibody or an antigen-binding portion thereof. Methods of making and methods of using the antibodies if the invention are also provided. The antibodies, or antibody portions, of the invention are useful for detecting two different but structurally related antigens (e.g., il-1 alpha and il-1 beta) and for inhibiting the activity of the antigens, (e.g., in a human subject suffering from a disorder in which il-1 alpha and/or il-1 beta activity is detrimental.
As Attached
| # | Name | Date |
|---|---|---|
| 1 | 1500-MUMNP-2007-CORRESPONDENCE(23-10-2012).pdf | 2012-10-23 |
| 2 | 1500-MUMNP-2007 -MUM-REPLY TO HEARING(14-12-2012).pdf | 2012-12-14 |
| 3 | 1500-MUMNP-2007 -MUM-MARKED COPY(14-12-2012).pdf | 2012-12-14 |
| 4 | 1500-MUMNP-2007 -MUM-FORM 13(14-12-2012).pdf | 2012-12-14 |
| 5 | 1500-MUMNP-2007 -MUM-CLAIMS(AMENDED)-(14-12-2012).pdf | 2012-12-14 |
| 6 | Form-5.doc | 2018-08-09 |
| 8 | Form-1.pdf | 2018-08-09 |
| 9 | 1500-MUMNP-2007_EXAMREPORT.pdf | 2018-08-09 |
| 10 | 1500-MUMNP-2007-US DOCUMENT(8-6-2012).pdf | 2018-08-09 |
| 11 | 1500-MUMNP-2007-US DOCUMENT(7-12-2011).pdf | 2018-08-09 |
| 12 | 1500-MUMNP-2007-TAIWAN DOCUMENT(7-12-2011).pdf | 2018-08-09 |
| 13 | 1500-mumnp-2007-sequence listing(21-9-2007).pdf | 2018-08-09 |
| 14 | 1500-MUMNP-2007-REPLY TO EXAMINATION REPORT(8-6-2012).pdf | 2018-08-09 |
| 15 | 1500-MUMNP-2007-POLISH DOCUMENT(7-12-2011).pdf | 2018-08-09 |
| 16 | 1500-MUMNP-2007-NEW ZEALAND DOCUMENT(7-12-2011).pdf | 2018-08-09 |
| 17 | 1500-MUMNP-2007-MEXICAN DOCUMENT(7-12-2011).pdf | 2018-08-09 |
| 18 | 1500-MUMNP-2007-KOREA DOCUMENT(7-12-2011).pdf | 2018-08-09 |
| 19 | 1500-MUMNP-2007-JAPANESE DOCUMENT(7-12-2011).pdf | 2018-08-09 |
| 20 | 1500-MUMNP-2007-ISRAEL DOCUMENT(7-12-2011).pdf | 2018-08-09 |
| 21 | 1500-MUMNP-2007-GENERAL POWER OF ATTORNEY(8-6-2012).pdf | 2018-08-09 |
| 22 | 1500-MUMNP-2007-GENERAL POWER OF ATTORNEY(1-10-2013).pdf | 2018-08-09 |
| 23 | 1500-MUMNP-2007-FORM 6(1-10-2013).pdf | 2018-08-09 |
| 24 | 1500-mumnp-2007-form 5(21-9-2007).pdf | 2018-08-09 |
| 25 | 1500-MUMNP-2007-FORM 3(7-12-2011).pdf | 2018-08-09 |
| 26 | 1500-mumnp-2007-form 3(4-4-2008).pdf | 2018-08-09 |
| 27 | 1500-mumnp-2007-form 3(4-2-2008).pdf | 2018-08-09 |
| 28 | 1500-MUMNP-2007-FORM 3(24-8-2012).pdf | 2018-08-09 |
| 29 | 1500-mumnp-2007-form 3(21-9-2007).pdf | 2018-08-09 |
| 30 | 1500-MUMNP-2007-FORM 3(16-6-2010).pdf | 2018-08-09 |
| 31 | 1500-mumnp-2007-form 2(title page)-(21-9-2007).pdf | 2018-08-09 |
| 32 | 1500-MUMNP-2007-FORM 2(TITLE PAGE)-(1-10-2013).pdf | 2018-08-09 |
| 33 | 1500-mumnp-2007-form 2(21-9-2007).pdf | 2018-08-09 |
| 34 | 1500-mumnp-2007-form 18(28-9-2007).pdf | 2018-08-09 |
| 35 | 1500-MUMNP-2007-FORM 13(8-6-2012).pdf | 2018-08-09 |
| 36 | 1500-mumnp-2007-form 1(21-9-2007).pdf | 2018-08-09 |
| 37 | 1500-MUMNP-2007-FORM 1(1-10-2013).pdf | 2018-08-09 |
| 38 | 1500-MUMNP-2007-EP DOCUMENT(8-6-2012).pdf | 2018-08-09 |
| 39 | 1500-MUMNP-2007-EP DOCUMENT(7-12-2011).pdf | 2018-08-09 |
| 40 | 1500-mumnp-2007-description(complete)-(21-9-2007).pdf | 2018-08-09 |
| 41 | 1500-MUMNP-2007-CORRESPONDENCE(IPO)-(ORDER)-(16-9-2016).pdf | 2018-08-09 |
| 42 | 1500-MUMNP-2007-CORRESPONDENCE(IPO)-(HEARING NOTICE)-(26-7-2012).pdf | 2018-08-09 |
| 43 | 1500-MUMNP-2007-CORRESPONDENCE(IPO)-(HEARING NOTICE)-(25-4-2016).pdf | 2018-08-09 |
| 44 | 1500-MUMNP-2007-CORRESPONDENCE(IPO)-(FER)-(10-6-2011).pdf | 2018-08-09 |
| 45 | 1500-MUMNP-2007-CORRESPONDENCE(8-8-2012).pdf | 2018-08-09 |
| 46 | 1500-MUMNP-2007-CORRESPONDENCE(7-12-2011).pdf | 2018-08-09 |
| 47 | 1500-mumnp-2007-correspondence(4-4-2008).pdf | 2018-08-09 |
| 48 | 1500-MUMNP-2007-CORRESPONDENCE(24-8-2012).pdf | 2018-08-09 |
| 49 | 1500-MUMNP-2007-CORRESPONDENCE(24-8-2012)-.pdf | 2018-08-09 |
| 50 | 1500-MUMNP-2007-CORRESPONDENCE(16-6-2010).pdf | 2018-08-09 |
| 51 | 1500-MUMNP-2007-CORRESPONDENCE(1-10-2013).pdf | 2018-08-09 |
| 52 | 1500-MUMNP-2007-CLAIMS(MARKED COPY)-(8-6-2012).pdf | 2018-08-09 |
| 53 | 1500-MUMNP-2007-CLAIMS(AMENDED)-(8-6-2012).pdf | 2018-08-09 |
| 54 | 1500-mumnp-2007-claims(21-9-2007).pdf | 2018-08-09 |
| 55 | 1500-MUMNP-2007-CHINA DOCUMENT(7-12-2011).pdf | 2018-08-09 |
| 56 | 1500-MUMNP-2007-CANADA DOCUMENT(7-12-2011).pdf | 2018-08-09 |
| 57 | 1500-MUMNP-2007-BULGARIAN DOCUMENT(7-12-2011).pdf | 2018-08-09 |
| 58 | 1500-MUMNP-2007-BRAZILLIA DOCUMENT(7-12-2011).pdf | 2018-08-09 |
| 59 | 1500-MUMNP-2007-AUSTRALIAN DOCUMENT(7-12-2011).pdf | 2018-08-09 |
| 60 | 1500-mumnp-2007-assignment(4-4-2008).pdf | 2018-08-09 |
| 61 | 1500-MUMNP-2007-ASSIGNMENT(1-10-2013).pdf | 2018-08-09 |
| 62 | 1500-mumnp-2007-abstract(21-9-2007).pdf | 2018-08-09 |